Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Artificial Larynx Helps Cancer Patient Speak and Smell

By HospiMedica International staff writers
Posted on 17 Jan 2017
A new study describes how an artificial larynx implanted after total laryngectomy allows a 56-year-old man to speak with an intelligible whisper and breathe normally.

Developed by researchers at CHU de Strasbourg, the French National Institute of Health and Medical Research (INSERM), and Institut Claudius Regaud, the ENTegral artificial larynx consists of a permanent titanium tracheal prosthesis with a porous distal end to improve soft-tissue integration, and a removable titanium cap that replicates the function of the epiglottis, allowing continuous passage of air and fluids while protecting the patient’s airway from aspiration. More...
When the patient coughs, the upper flap can open transiently to allow the expulsion of bronchopulmonary secretions.

The patient in question underwent total laryngectomy and bilateral cervical lymphadenectomy. In phase 1 of the procedure, the permanent tracheal prosthesis was implanted with a temporary closed cap. Four months later, in phase 2, it was removed and replaced with a removable open-ventilation cap. During a 16-month follow-up period, stenosis did not develop at the trachea–prosthesis anastomosis, and the patient could breathe and expectorate through the upper airways and maintain adequate arterial blood hemoglobin saturation while breathing ambient air.

The patient was able to speak and swallow saliva during the day and at night, although occasional aspiration of food occurred. The patient’s olfaction, which had also been compromised, was completely restored. In addition, the artificial larynx did not interfere with any planned radiotherapy, and the patient wasalso able to close the fenestrated tracheostomy cannula for six or more hours per day in order to breathe through the upper airways. The study describing the artificial larynx was published in the January 5, 2017, issue of the New England Journal of Medicine (NEJM).

“No episodes of pneumonia, infection, discharge, difficulty breathing or blockages were observed after 16 months of daily use. This implant is constantly evolving and the next patients will benefit from substantial improvements to improve the passage of food down the throat,” said study co-author Nihal Engin Vrana, PhD, of INSERM. “Patients who have had a total laryngectomy are the ideal candidates for this device. However, following surgery, they still must have the base of their tongue, to help preserve swallowing function.”

The larynx, also called the voice box, houses the vocal cords, which are essential for phonation. It also manipulates the pitch and volume of sounds produced. Located in the neck of tetrapods, the larynx is also involved in breathing and protecting the trachea against food aspiration. The laryngeal skeleton consists of six cartilages: three single (epiglottic, thyroid and cricoid) and three paired (arytenoid, corniculate, and cuneiform).


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.